Insider buying last 90 days
No open-market insider purchases were filed for PG in the last 90 days.
From Form 4 filings, dated to when each was filed.
Close on Sep 18, 2026. Page updated Sep 19, 9:14 pm ET.
Procter & Gamble trades at $146.39, down 0.8%, sitting between its 50-day average of $146.12 and 200-day average of $147.46, a mixed trend signal. The GekkoIndex reads 55.5, placing the stock in the Neutral zone. Gekko Fair Value stands at $173.79, leaving a gap of -15.8% versus the current price.
This week's coverage centers on a mix of political, structural, and strategic threads. Ohio Congressman David J. Taylor purchased PG shares valued between $1,001 and $15,000 on 8 September 2026 through the David Taylor Trust. Separately, P&G's ongoing restructuring has cut about 5,000 jobs, with related commentary on tax implications for departing workers holding company stock. On the operational side, P&G and Siemens are expanding a global AI-based quality inspection system, the Visual Inspection Cockpit, across manufacturing operations, described as reducing scrap rates by 10-20%. Nykredit A/S disclosed a new position of 1.32 million shares valued at approximately $193.1 million, and P&G's quarterly dividend of $1.0885 per share, yielding 3.0%, was noted alongside recent EPS results.
Looking ahead, P&G's next earnings report is scheduled for 22 October 2026 before the open, 32 days out and beyond a typical 20-trading-day holding window. Congress activity over the past 90 days shows 5 buys and 0 sells. Seasonality over the next 20 trading days has averaged -3.3% across 5 years, with 0 of those years positive. Analyst coverage includes 9 buy and 10 hold ratings among 19 firms, with a consensus target of $160.61.
Written by AI and checked automatically against the figures on this page. Generated Sep 20, 2026 from the data above.
Procter & Gamble scores 3 supportive, 2 mixed and 1 headwind across the 6 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed1 headwind
Averages disagree
Close $146.39 sits between the 50-day ($146.12) and 200-day ($147.46) averages, or the averages disagree.
See the chart55.5, Neutral
Reading 55.5 is in the Neutral zone.
See the GekkoIndex15.8% below
Price is 15.8% below Gekko Fair Value (more than 5% below).
See fair valueLeans bullish
Last 90 days: Congress 5 buys / 0 sales.
See smart moneyReports in 32 days
Next report Oct 22, 2026, 32 days away — outside a typical 20-trading-day hold.
See earnings−3.3% on average
From this point in the calendar, the next 20 trading days averaged −3.3% over 5 years, rising in 0 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Procter & Gamble closed at $146.39 on Sep 18, 2026, −8.7% over the past year, inside a 52-week range of $137.62 to $167.25.
Use the left and right arrow keys to read daily values.
Put PG on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Procter & Gamble makes and markets a wide range of branded household and personal items sold to consumers around the world. Its shelves span hair care, skin care and grooming names such as Pantene, Olay, Gillette and Venus, alongside oral care and health items like Crest, Oral-B, Pepto-Bismol and Vicks. The company is also known for laundry and home cleaning brands including Tide, Downy, Dawn and Swiffer, plus paper and family care products such as Pampers, Always, Bounty and Charmin.
The business is organized into five segments covering beauty, grooming, health care, fabric and home care, and baby, feminine and family care, each built around its own set of brand names. Products reach shoppers through a wide mix of channels, including large retailers, grocery and club stores, pharmacies, department stores, specialty beauty and electronics outlets, wholesalers and distributors, professional cleaning channels, e-commerce, and direct sales to consumers.
Procter & Gamble shares trade on the NYSE under the ticker PG.
Procter & Gamble’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 55.5, in the Neutral zone, down 3.7 points over five sessions.
Down 3.7 points over five sessions.
Reading for Sep 18, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 26 | +2.2% | +4.0% | ||
| Accumulation | 231 | +0.3% | +0.6% | ||
| Neutral (current zone) | 380 | −0.3% | −0.8% | ||
| Distribution | 23 | −0.8% | −1.0% | ||
| Selling | 2 | Too few readings yet | |||
Average PG share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.2% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Procter & Gamble trades 15.8% below Gekko Fair Value of $173.79, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Procter & Gamble shares are worth, recalculated every trading day.
$173.79
Gekko Fair Value, Sep 19, 2026
15.8% Undervalued
No open-market insider purchases were filed for Procter & Gamble, and members of Congress disclosed 5 purchases and 0 sales, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for PG in the last 90 days.
From Form 4 filings, dated to when each was filed.
5trades disclosed: 5 purchases and 0 sales.
| Member | Amount | Disclosed |
|---|---|---|
| David Taylor House, OH, purchase | $1,001 - $15,000 | Sep 18 traded Sep 8 |
| Lloyd Doggett House, TX, purchase | $1,001 - $15,000 | Sep 9 traded Aug 17 |
| Lloyd Alton Doggett House, TX, purchase | $1,001 - $15,000 | Sep 9 traded Aug 16 |
| David Taylor House, OH, purchase | $1,001 - $15,000 | Aug 21 traded Aug 11 |
| David J. Taylor House, OH, purchase | $1,001 - $15,000 | Aug 21 traded Aug 10 |
From congressional disclosures, which report amounts as ranges.
Procter & Gamble has been buying back its own shares.
From company filings.
1of the funds Gekko tracks holds PG.
Procter & Gamble reports on Oct 22, 2026, before the open (32 days away), and beat the EPS estimate in 8 of its last 8 reports.
Oct 22, 2026
Expected before the open, 32 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Jul 29, 2026 | $1.43 est $1.41 | $21.20B est $21.38B | −3.3% |
| Apr 24, 2026 | $1.59 est $1.56 | $21.24B est $20.53B | +1.8% |
| Jan 22, 2026 | $1.88 est $1.86 | $22.21B est $22.30B | +2.8% |
| Oct 24, 2025 | $1.99 est $1.90 | $22.39B est $22.18B | −0.3% |
| Jul 29, 2025 | $1.48 est $1.42 | $20.89B est $20.84B | −2.7% |
| Apr 24, 2025 | $1.54 est $1.52 | $19.78B est $20.15B | −2.8% |
| Jan 22, 2025 | $1.88 est $1.86 | $21.88B est $21.58B | +2.7% |
| Oct 18, 2024 | $1.93 est $1.90 | $21.74B est $21.99B | −1.6% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Procter & Gamble is $160.61, +9.7% from the last close, from 19 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 19 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 15 | Jefferies | $177 | +20.9% |
| Sep 15 | Bernstein | $149 | +1.8% |
| Sep 11 | Barclays | $152 | +3.8% |
| Sep 11 | Evercore ISI | $161 | +10.0% |
| Aug 19 | RBC Capital | $167 | +14.1% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 19, Procter & Gamble averaged −3.3% across the last 5 years, rising in 0 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | −1.7% | 0 of 5 |
| Next 10 trading days | −3.7% | 0 of 5 |
| Next 15 trading days | −4.6% | 0 of 5 |
| Next 20 trading days | −3.3% | 0 of 5 |
| Next 30 trading days | −2.6% | 0 of 5 |
For scale, PG’s typical 20-trading-day move in either direction is about 3%.
Procter & Gamble’s market cap is $347.9B, with a P/E ratio of 22.2 and revenue of $87.03B over the last twelve months.
Coverage of Procter & Gamble this week reads positive: 6 positive, 1 neutral and 2 negative headlines.
Procter & Gamble’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| CLColgate-Palmolive | Accumulation | 3.3% below |
| KVUEKenvue | Accumulation | 22.7% below |
| ELEstee Lauder Companies | Accumulation | 4.2% below |
| KMBKimberly-Clark | Buying | 19.5% below |
| CHDChurch & Dwight | Accumulation | 7.1% below |
| CLXClorox | Buying | 45.5% below |
A peer links to its own page where one exists.
Procter & Gamble’s market cap is $347.9B at the Sep 18, 2026 close of $146.39, with 2.32B shares outstanding. The shares trade on a P/E ratio of 22.2.
The consensus analyst 12-month price target for Procter & Gamble is $160.61, +9.7% from the last close. Of the 19 firms that rated the stock in the last 90 days, 9 rate it a buy, 10 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Procter & Gamble is undervalued: the Sep 18, 2026 close of $146.39 is 15.8% below Gekko Fair Value of $173.79. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Procter & Gamble is expected to report on Oct 22, 2026, before the market opens (32 days away). Analysts expect earnings of $1.89 per share on revenue of $22.72B. Procter & Gamble beat the earnings estimate in 8 of its last 8 reports, moving 2.3% on average across the report.
Procter & Gamble’s 52-week high is $167.25 and its 52-week low is $137.62; it closed at $146.39 on Sep 18, 2026, −8.7% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 6 items with data read as supportive (fair value, smart money and earnings risk), 2 as mixed (trend and gekkoindex) and 1 as a headwind (seasonality). The checklist is a description of current data, not a recommendation.
Prices and signals update after every US market close; the GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,349 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.